Phase I study of safety and immunogenicity of ADU-623, a live-attenuated listeria monocytogenes vaccine (ΔactA/ΔinlB) expressing EGFRVIII and NY-ESO-1, in patients with who grade III/IV astrocytomas
Marka Crittenden, Keith S Bahjat, Rui Li, Pankaj Gore, Chris Fountain, Bill Hanson, Justin Skoble, Peter Lauer, Aimee L Murphy, Thomas Dubensky, Dirk G Brockstedt, Walter Urba
Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P162; DOI: 10.1186/2051-1426-3-S2-P162
